ADPGK and neoplasm: Furthermore, MnOx@HMSN(CDA+AH1) treatment substantially suppressed the growth of both primary and distant tumors, whereas soluble formulations showed no antitumor activity.[100f] The platform was also applied to another tumor‐specific neoantigen Adpgk, derived from MC38 colorectal carcinoma.